Buy-and-bill or specialty pharmacy? That changes who acquires and bills the expensive medicine.

In a traditional provider buy-and-bill model, the clinic or hospital acquires the medicine, administers it and bills the payer for the drug and administration under the applicable benefit. In a specialty-pharmacy model, a pharmacy may dispense a patient-specific product that is later administered by the clinic.

The correct path depends on the payer, product, plan contract and treatment-site capabilities. Patients should not be asked to solve the procurement model alone.

Buy-and-bill usually keeps drug acquisition with the provider

The treatment site purchases the drug through its supply chain and bills after administration. Coverage still depends on authorization, product preference, code/units, network and site rules.

The patient should verify the expected benefit and cost-sharing framework, not the provider’s acquisition cost.

Specialty-pharmacy sourcing separates dispensing from administration

A specialty pharmacy may bill for or adjudicate the drug while the clinic bills for administration. That can create separate authorizations, claims or cost-sharing questions depending on the plan.

Confirm whether the specialty pharmacy is mandatory and whether the administration site is separately in network and authorized.

Use one written routing plan before the appointment

Ask the clinic to document who is obtaining the drug, who is billing the drug, who is billing administration, which benefit applies and which authorization numbers are required.

If insurer and clinic give different answers, resolve the discrepancy before shipment or treatment whenever possible.

Use the source that actually controls your case

MedicineCostHelp can organize the problem, but the member-specific plan, payer decision, provider record or assistance program makes the actual determination. Keep written decisions, reference numbers and the documents that support the next step.